These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24656735)

  • 1. Does patient age still affect receipt of adjuvant therapy for colorectal cancer in New South Wales, Australia?
    Jorgensen ML; Young JM; Dobbins TA; Solomon MJ
    J Geriatr Oncol; 2014 Jul; 5(3):323-30. PubMed ID: 24656735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of variation in colorectal cancer care and outcomes in New South Wales: a population-based health data linkage study.
    Jorgensen ML; Young JM; Dobbins TA; Solomon MJ
    Med J Aust; 2014 Apr; 200(7):403-7. PubMed ID: 24794673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.
    Ayanian JZ; Zaslavsky AM; Fuchs CS; Guadagnoli E; Creech CM; Cress RD; O'Connor LC; West DW; Allen ME; Wolf RE; Wright WE
    J Clin Oncol; 2003 Apr; 21(7):1293-300. PubMed ID: 12663717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
    Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
    BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services.
    Barton MB; Gabriel GS; Miles S
    ANZ J Surg; 2004 Jun; 74(6):406-12. PubMed ID: 15191469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.
    Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M
    Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer.
    Segelman J; Akre O; Gustafsson UO; Bottai M; Martling A
    Colorectal Dis; 2014 May; 16(5):359-67. PubMed ID: 24410859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of referral for adjuvant therapy for colorectal cancer.
    Ong S; Watters JM; Grunfeld E; O'Rourke K
    Can J Surg; 2005 Jun; 48(3):225-9. PubMed ID: 16013627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer.
    Earle CC; Weiser MR; Ter Veer A; Skibber JM; Wilson J; Rajput A; Wong YN; Benson AB; Shibata S; Romanus D; Niland J; Schrag D
    J Surg Oncol; 2009 Dec; 100(7):525-8. PubMed ID: 19697351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer.
    McGory ML; Zingmond DS; Sekeris E; Bastani R; Ko CY
    Dis Colon Rectum; 2006 Mar; 49(3):319-29. PubMed ID: 16475031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy in colorectal cancer.
    Parshad R
    Trop Gastroenterol; 1997; 18(4):139-44. PubMed ID: 9612092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer.
    Hsieh MC; Chiu YW; Velasco C; Wu XC; O'Flarity MB; Chen VW
    J Registry Manag; 2013; 40(4):180-7. PubMed ID: 24625772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel data-driven prognostic model for staging of colorectal cancer.
    Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
    J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study.
    Ahmed S; Ahmad I; Zhu T; Arnold FP; Faiz Anan G; Sami A; Yadav SK; Alvi R; Haider K
    Dis Colon Rectum; 2010 Oct; 53(10):1432-8. PubMed ID: 20847626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival after pelvic exenteration for T4 rectal cancer.
    Kusters M; Austin KK; Solomon MJ; Lee PJ; Nieuwenhuijzen GA; Rutten HJ
    Br J Surg; 2015 Jan; 102(1):125-31. PubMed ID: 25451182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of abdominoperineal resection rate as a surrogate marker of hospital quality in rectal cancer surgery.
    Jorgensen ML; Young JM; Dobbins TA; Solomon MJ
    Br J Surg; 2013 Nov; 100(12):1655-63. PubMed ID: 24264791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
    Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
    J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy for colon and rectal cancer.
    Ratkin GA
    Am Fam Physician; 1997 May; 55(7):2487-92, 2495-6. PubMed ID: 9166147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada.
    Eldin NS; Yasui Y; Scarfe A; Winget M
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.